Evaxion A (EVAX) Other Gross PP&E Adjustments (2020 - 2022)
Evaxion A (EVAX) reported Other Gross PP&E Adjustments of $4.7 million for Q2 2022, up 127.55% on a YoY basis from $2.1 million in Q2 2021, and down 7.57% quarter-over-quarter from $5.1 million in Q1 2022.
Evaxion A (EVAX) Other Gross PP&E Adjustments (2020 - 2022) Analysis & Trends
Evaxion A has reported Other Gross PP&E Adjustments for 3 years, with the latest figure at $4.7 million in Q2 2022.
- For the quarter ending Q2 2022, Other Gross PP&E Adjustments rose 127.55% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2022 stood at $4.7 million (up 127.55% YoY), and the FY2021 full-year result was $5.2 million, up 2241.18% from the prior year.
- Other Gross PP&E Adjustments for Q2 2022 stood at $4.7 million, down from $5.1 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $5.2 million in Q4 2021, with the low at $221000.0 in Q4 2020.
- Historically, Other Gross PP&E Adjustments has averaged $3.4 million across 3 years, with a median of $4.7 million in 2022.
- Annual changes were most pronounced in 2021 — Other Gross PP&E Adjustments surged 2241.18% — and 2022, when it soared 127.55%.
- Evaxion A's Other Gross PP&E Adjustments stood at $221000.0 in 2020, then surged by 2241.18% to $5.2 million in 2021, then slipped by 8.7% to $4.7 million in 2022.
- The last three Other Gross PP&E Adjustments figures came in at $4.7 million (Q2 2022), $5.1 million (Q1 2022), and $5.2 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -60,691.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -892,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 4.72 Mn |
| Jun 30, 2022 | 4.72 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | 221,000.00 |
| Dec 31, 2020 | 221,000.00 |